Tsai Philip

Tsai Philip is listed in filings as Chief Technology Officer at Immunome, Inc.. This profile follows SEC Form 4 activity through Dec 22, 2025, including purchase activity. Recent filings connect the profile to Immunome, Inc. (IMNM). The current snapshot covers public activity from Jun 18, 2024 to Dec 22, 2025. Reported amounts are shown as $3.3M to $103.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.